KGOG 2015
Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer
KGOG
KGOG 2029/ SELYE
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial
Trial Number
NCT04845828 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
KGOG 3046/ TRU-D
A phase II study of neoadjuvant chemotherapy plus tremelimumab and durvalumab in advanced-stage ovarian cancer
Trial Number
NCT03899610 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
KGOG 3045/ AMBITION
An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer
Trial Number
NCT03699449 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
KGOG 3056 / NIRVANA-R
A single-arm phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive ovarian cancer patients previously treated with a PARP inhibitor
Trial Number
NCT04734665 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
KGOG 3064/ KROG 2204/ SABR-ROC
Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy with or without Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer
Trial Number
NCT05444270 ( ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
KGOG 1047/ DEBULK
Therapeutic effect of surgical debulking of metastatic lymph nodes in cervical cancer stage IIICr: A phase III, randomized controlled clinical trial
Trial Number
NCT05421650 (ClinicalTrials.gov Identifier)Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
TACO
Tri-weekly Administration of Cisplatin in Locally Advanced Cervical Cancer